Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06549348 · ClinicalTrials.gov registry record · NA
Radiation Free Study
A NA study of Aortic Aneurysm, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 9
- Study locations
NCT06549348: Recruiting NA study of Aortic Aneurysm, sponsored by Philips Clinical & Medical Affairs Global.
NCT06549348 is a NA study of Aortic Aneurysm that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 182 participants, below the 627-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (71% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06549348, a NA study of Aortic Aneurysm, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable. Primary objective is to demonstrate that the average procedure fluoroscopy time using LumiGuide is lower compared to conventional fluoroscopy guidance in Fenestrated Endovascular Aortic Repair (FEVAR)
Primary Outcome
Procedure fluoroscopy time
Conditions Studied
Interventions
- RADIATION Measure average procedure fluoroscopy time using LumiGuide and conventional fluoroscopy guidance
Study Locations (9)
Other
- UZ Gent - Ghent
- Rigshospitalet University Hospital - Copenhagen
- Hôpital Universitaire Pitié-Salpêtrière - Paris
- UMC Maastricht - Maastricht
- Guys & St Thomas - London
Alabama
- University of Alabama - Birmingham
Massachusetts
- University of Massachusetts - Worcester
Pennsylvania
- University of Pennsylvania - Philadelphia
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06549348 shows while recruiting
NCT06549348 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 627-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Measure average procedure fluoroscopy time using LumiGuide and conventional fluoroscopy guidance is the first listed.
NCT06549348 lists 9 locations in 5 states (Other, Alabama, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06549348 about?
NCT06549348 is a clinical study titled "Radiation Free Study". This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable. Primary objective is to demonstrate that the average procedure fluoroscopy time using LumiGuide...
What is the current status of trial NCT06549348?
This trial is currently recruiting. It is a NA study. The enrollment target is 182 participants. The study started on 2025-07-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06549348 study?
This clinical trial studies the following conditions: Aortic Aneurysm.
What interventions are being tested in trial NCT06549348?
The interventions under investigation include: Measure average procedure fluoroscopy time using LumiGuide and conventional fluoroscopy guidance (RADIATION).
Who is sponsoring clinical trial NCT06549348?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06549348 being conducted?
This trial has 9 study locations across Alabama, Massachusetts, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06549348's enrollment target sits among peer trials
182 6th of 14 higher than 9 of 14 other Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Physiology in Patients With Aortic Aneurysm and Its Correlation With Mechanical Properties of Aortic Tissue
RECRUITING · NA
-
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial
RECRUITING · NA
-
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
RECRUITING · NA
-
Laser In Situ Fenestration Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI